Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ZO

WKN: A420P0 | ISIN: KYG989GD1011 | Ticker:
NASDAQ
18.11.26 | 22:00
6,170 US-Dollar
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ZOAR LIMITED Chart 1 Jahr
5-Tage-Chart
ZOAR LIMITED 5-Tage-Chart

Aktuelle News zur ZOAR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiNSE - IMPACT BIOMEDICAL INC. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities2
MiDSS, Inc.: DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited299Transaction marks a significant milestone for DSS's investment in Impact Biomedical and establishes Zoar Limited as an NYSE American-listed pharmaceutical companyZoar Limited ordinary shares expected...
► Artikel lesen
MiZoar Ltd - 6-K, Report of foreign issuer-
DiIMPACT BIOMEDICAL INC. - 8-K, Current Report-
ZOAR Aktie jetzt für 0€ handeln
DiZoar Ltd - 8-A12B, Registration of securities-
09.11.IMPACT BIOMEDICAL INC. - 10-Q, Quarterly Report-
03.11.IMPACT BIOMEDICAL INC. - 8-K, Current Report1
03.11.Impact Biomedical, Inc.: Impact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination604Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard TimeUpon closing, the combined company...
► Artikel lesen
09.10.IMPACT BIOMEDICAL INC. - 8-K, Current Report-
16.09.Impact Biomedical files F-4 for business combination2
16.09.Fusion mit Zoar Labs: Impact Biomedical reicht F-4-Antrag ein2
16.09.DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical's Proposed Business Combination with Zoar Limited2
16.09.Impact BioMedical, Inc.: Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Limited557HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (NYSE: IBO) (the "Company" or "Impact") announced that a Form F-4 registration statement (the "Registration Statement") was filed with...
► Artikel lesen
15.09.Impact Biomedical corrects merger exchange ratio, sets reverse stock split1
15.09.Impact BioMedical, Inc. Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited313HOUSTON, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Impact Biomedical Inc (NYSE: IBO) today announced that the Company's Board of Directors has approved a 1 for 12.62 reverse stock split of the Company's issued...
► Artikel lesen
11.09.Impact BioMedical beschließt Aktienzusammenlegung im Verhältnis 1 zu 12,621
11.09.Impact BioMedical approves 1-for-12.62 reverse stock split1
07.08.IMPACT BIOMEDICAL INC. - 10-Q, Quarterly Report1
03.04.Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans311HOUSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO) announced that its annual report(10-K) for the fiscal year ending December 31, 2025, filed on March 11, 2026...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1